Toronto, Canada, October 7, 2008 - SQI Diagnostics Inc. (TSX-Venture: SQD), a medical systems automation company focused on evolving laboratory-based biomarker testing, announced today that Thomas O'Connor has been appointed the Company's Senior Vice President, Sales and Marketing.
brings to SQI
more than two decades of experience in sales and marketing, sales team leadership, management and business development, during which he
consistently exceeded targets and grew business and market share.
Mr. O'Connor has held positions as Vice President of Sales, Business Development Manager, and North America Sales Manager for companies such as Luminex Corporation (NASDAQ: LMNX), a world leader in multiplexing, Beckman Coulter, Inc. (NYSE: BEC), a leader of automation in clinical diagnostics, and Exagen Diagnostics, Inc., an innovator of genomic marker testing and molecular diagnostics.
proven ability to effectively build market share and his
familiarity with our target customer base will enable SQI
to capitalize on the significant growth in the demand for biomarker testing across a range of diseases."
will be based in the U.S. and will be responsible for building SQI's
multiplex immunoassay platform franchise in North America and Europe.
intends to file an application with the United States Food and Drug Administration seeking clearance to market its SQiDworks Platform and lead test QuantiSpot RA microarray in the U.S.
automated technology significantly improves upon the current industry standard methods for biomarker testing, which are labour intensive and inefficient," said Thomas O'Connor